bpc-157 multiple sclerosis trial bpc 157 clinical humans Failed, Inconclusive or Interrupted Trials in Sclerosis: 2020-2024 Update Frontiers Stable Gastric Pentadecapeptide BPC 157

5.2 Hypopituitarism In the Iglesias study, hypopituitarism at the time of PRLoma diagnosis was found in about 75% of patients and was more frequently diagnosed in patients with macro- than microPRLomas (111, 130133), which most likely should be related to tumor diameter (134)

Obesity Drug Trial Produces Disappointing Weight Loss (axokine).The New York Times

[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Son B.R., Marquez-Curtis L.A., Kucia M., Wysoczynski M., Turner A.R., Ratajczak J., Janowska-Wieczorek A

Some protocols use longer cycles or maintenance dosing

This is due to the copper content and resolves on its own